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Blood lipid levels, including low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol
(HDL-C) and triglycerides (TG), are highly heritable traits and major risk factors for atherosclerotic cardiovas-
cular disease (CVD). Using individual ancestry estimates at marker locations across the genome, we present
a novel quantitative admixture mapping analysis of all three lipid traits in a large sample of African-Americans
from the Family Blood Pressure Program. Regression analysis was performed with both total and marker-
location-specific European ancestry as explanatory variables, along with demographic covariates. Robust
permutation analysis was used to assess statistical significance. Overall European ancestry was significantly
correlated with HDL-C (negatively) and TG (positively), but not with LDL-C. We found strong evidence for a
novel locus underlying HDL-C on chromosome 8q, which correlated negatively with European ancestry
(P 5 .0014); the same location also showed positive correlation of European ancestry with TG levels. A
region on chromosome 14q also showed significant negative correlation between HDL-C levels and
European ancestry. On chromosome 15q, a suggestive negative correlation of European ancestry with TG
and positive correlation with HDL-C was observed. Results with LDL-C were less significant overall.
We also found significant evidence for genome-wide ancestry effects underlying the joint distribution of
HDL-C and TG, not fully explained by the locus on chromosome 8. Our results are consistent with a genetic
contribution to and may explain the healthier HDL-C and TG profiles found in Blacks versus Whites. The
identified regions provide locations for follow-up studies of genetic variants underlying lipid variation in
African-Americans and possibly other populations.
INTRODUCTION
Cardiovascular disease (CVD) is a leading cause of morbidity
and mortality, making it a major public health concern world-
wide (1). The etiology of the disease is multifactorial, with
established genetic and environmental risk factors (2–5).
Atherosclerosis, which is characterized by lipid accumulation,
inflammatory response, cell death and fibrosis in arterial walls,
accounts for 75% of all deaths from CVD (6). There is com-
pelling evidence of involvement of blood lipid concentrations
in atherosclerosis and CVD (7–9). Blood lipids are complex
traits influenced by both genetic and environmental factors
(2–5,10). Heritability estimates for lipid concentrations
vary [40–75% for high-density lipoprotein cholesterol
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(HDL-C), 40–65% for low-density lipoprotein cholesterol
(LDL-C) and 35–50% for triglycerides (TG)] (11), yet are
consistently high for all lipid traits.
The genetic dissection of these complex traits has long been
a major challenge, and there have been many studies aimed at
finding specific loci for these phenotypes. Various study
designs have been employed, ranging from large-scale
genome-wide association (12–15) to candidate gene (16–
19) and linkage studies (6,20,21). Recently, Willer et al.
(15), in a large meta-analysis combining genome-wide scans
with 9000 individuals of European descent in stage 1 and
11 500 individuals of European descent in stage 2, found
convincing evidence for 11 loci (genes) previously implicated
in lipid metabolism as well as compelling evidence for several
newly identified loci (two for HDL-C, three for TG, one for
LDL-C and one region encompassing several genes associated
with both LDL-C and TG).
At the same time, there are known ethnic trends in lipid
levels (22,23). For example, after adjusting for socioeconomic
factors, African-Americans generally have healthier lipid
levels (lower TG and higher HDL-C) than people of European
descent (16,24,25), whereas both have healthier lipid levels
than South Asians (26,27). This underscores the importance
of undertaking large-scale mapping studies of populations
with distinct ethnic backgrounds.
New world admixed populations provide unique opportu-
nities for locating trait loci by genetic admixture mapping
(28–33). The African-American population of the United
States is typically characterized by admixture of European
and African ancestral genomes in different proportions with
some spatial variation (34–36). Studies have correlated
genome-wide African ancestry in African-Americans with
healthier lipid levels (37). In this report, we present results
of an admixture mapping analysis examining the correlation
of lipid levels (LDL-C, HDL-C and TG) with estimated
genome-wide ancestry proportions as well as ancestry esti-
mates at each of 284 marker loci distributed around the
genome in 1044 unrelated African-Americans subjects from
the Family Blood Pressure Program (FBPP), in a search for
locus-specific effects.
RESULTS
Sample demographics for the 1044 individuals are given in
Table 1. There were 698 females and 346 males. The subjects
from GENOA were on average older (average age 59.6) than
the HyperGEN subjects (average age 49.4). Within each
network, the average body mass index (BMI), HDL-C and
LDL-C were generally higher in females than in males,
whereas TG levels showed slightly reversed tendencies. The
male and female subjects from GENOA had higher HDL-C
and TG levels than their corresponding counterparts from
HyperGEN. There was little variation in BMI between net-
works. Average European ancestry varied modestly between
the two networks, as was previously noted (36).
LDL-C levels were modestly correlated with HDL-C and
TG levels (correlation coefficient 20.13 with HDL-C and
0.19 with TG). HDL-C and TG, as observed in other
studies, showed a stronger inverse correlation (20.28). The
correlation between the traits was virtually unaffected by the
transformations. By analysis of variance, all three lipid traits
were strongly associated with BMI and age (Table 2).
HDL-C was strongly associated with sex. TG and LDL-C dif-
fered significantly between networks.
LDL-C was not found to be correlated with overall Euro-
pean individual ancestry (IA) (P ¼ .80). On the other hand,
HDL-C was strongly negatively correlated with European IA
(t ¼ 22.76, P¼0.0059) and TG was strongly positively corre-
lated with European IA (t ¼ 3.29, P ¼ .0010).
A Q–Q plot of the rl values (standardized regression coeffi-
cients) for the 284 loci for LDL-C, TG and HDL-C showed a
reasonably good fit to normality (Fig. 1) except for some
outlier points, in particular at the low (negative) end of the dis-
tribution for HDL-C.
According to normal distribution theory, we expected 14
(5% of 284) marker positions to have an absolute standar-
dized regression coefficient jrlj value . 1.96, or seven in
Table 1. Demographic characteristics of unrelated study participants: Family Blood Pressure Program
GENOA HyperGEN
Male Female Male Female
Number of individuals 102 247 244 451
BMI 29.25+4.9 31.77+6.9 29.71+6.3 33.79+8.5
Age 61.83+8.3 58.77+9.6 49.17+12.3 49.53+12.3
HDL-C 52.96+18.6 60.37+18.8 50.25+15.3 55.98+15.1
LDL-C 110.06+43.4 121.01+38.1 119.15+34.4 120.97+36.9
TG 145.12+84.2 142.57+67.8 116.75+75.7 109.24+76.0
European ancestry (%) 14.2 15.57 13.35 12.16
Table 2. Analysis of variance results on LDL, HDL and TG
df F-value P-value
LDL-C
Log (log(BMI)) 1 30.18 4.99  1028
Age 1 14.41 1.56  1024
Sex 1 0.37 0.54
Network 1 6.31 0.012
HDL-C
Log (log(BMI)) 1 39.04 6.05  10210
Age 1 31.96 2.00  1028
Sex 1 78.39 ,2.2  10216
Network 1 0.20 0.66
TG
Log (log(BMI)) 1 18.03 2.37  10205
Age 1 74.66 ,2.2  10216
Sex 1 2.84 0.09
Network 1 53.44 5.31  10213
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each tail. However, we found an excess of points in the tails in
each of the three distributions. For LDL-C, there were seven rl
values . 1.96 as expected but 10 in the left tail (i.e. values
less than 21.96) (Supplementary Material, Table S1). For
HDL-C, there were 11 rl values . 1.96 (i.e. in the right tail)
and 10 in the left tail (less than 21.96) (Supplementary
Material, Table S2). For TG, there were 12 rl values . 1.96
(i.e. in the right tail) and eight in the left tail (Supplementary
Material, Table S3).
For LDL-C, the two most promising chromosomal regions
were at 3q and 4q, both showing negative correlation with
European ancestry. On 3q, five markers covering 64 cM had
Z-scores less than 22.0, with a peak of 22.35 at 188.3 cM
(marker D3S2427). On chromosome 4q, three markers had
Z-scores less than 22.0, with a peak of 22.33 at 78 cM
(marker D4S2367).
For HDL-C, two significant regions on chromosomes 8q
and 14q showed negative correlation with European ancestry,
whereas a region on chromosome 9q showed positive corre-
lation with European ancestry. Chromosome 8q had four
markers covering 27 cM with Z-scores less than 22.0, with
a peak of 24.13 at 82.3 cM (marker D8S1136). On chromo-
some 14q, three markers had Z-scores less than 22, with a
peak of 23.00 at 95.9 cM (marker GATA193A07). On
chromosome 9q, there were three markers with Z-scores .
2, with a peak of 2.69 at 110.9 cM.
The two most promising locations for TG included one
extended region positively correlated with European ancestry
on chromosome 8q and another negatively correlated with
European ancestry on chromosome 15q. On chromosome
15q, the peak Z-score of 22.75 occurred at 90.0 cM
(marker D15S652), whereas two neighboring markers also
had Z-scores less than 22. On chromosome 8q, an extended
region of 87 cM stretching from 77.9 to 164.5 cM contained
seven markers with Z-scores . 2. Two separate peaks
occurred in this interval, one at 135.1 cM with a Z-score of
2.58 (marker D8S1179) and the other at 77.9–82.3 cM
(markers D8S1113 and D8S1136) with a Z-score of 2.31.
We note that this is precisely the same location harboring
the most significant result for HDL-C (marker D8S1136).
To determine the statistical significance of our findings, we
employed a permutation test (see Materials and Methods).
For LDL-C and TG, none of the markers was significant at
P , 0.05. For HDL-C, however, in 5000 permutations, the
minimum of 284 rl scores crossed 24.13 only seven times,
23.01 seventy-three times and 22.99 ninety times. Hence,
the result associated with the marker D8S1136 is highly sig-
nificant on a genome-wide level (P ¼ 0.0014), whereas that
for D8S1113 and GATA193A07 are also formally significant
(P , 0.02).
We also looked at possible significant interactions of BMI,
age, sex, network, usage of lipid-lowering medication, and
hypertension status with local ancestry at the significant
genomic marker locations for all three lipid traits and did
not find any. The Z-scores for HDL-C and TG across chromo-
somes 8 and 14 are plotted in Figure 2, which also gives a
visual impression of the inverse relationship between the
two traits. We also examined the possibility of outlier points
driving the Z-scores for the three significant loci (Supplemen-
tary Material, Fig. S1) but found no evidence of outliers.
Furthermore, as another check on the robustness of our con-
clusions, we examined results of multiple additional analyses
based on different randomly selected sets of unrelated individ-
uals from the African-American families in our study. The
results for these subsets were essentially identical to those
we obtained in the original analysis, indicating that our
results were not dependent on the original selection of unre-
lated individuals from these families.
Our results also indicated an overall genome-wide ancestry
deviation in opposite directions for HDL-C and TG. To
determine whether multiple loci are influential in the joint
distribution of these lipid traits, we looked at the correlation
between the regression coefficients of the 284 markers for
the two lipids. If a common set of genes is responsible, for
example, for both high HDL-C and low TG values, then we
would observe a large negative correlation between the ances-
try regression coefficients.
For the 284 markers, the correlation between the regression
coefficients for HDL-C and TG was 20.55. To determine stat-
istical significance of this correlation, we performed 5000 per-
mutations (as described in Materials and Methods), and for
each permutation calculated the pairwise correlation between
the ancestry regression coefficients for the two lipid traits.
Out of 5000 permutations, the correlation exceeded 20.55
only 70 times, which corresponds to a P-value of .014. After
removing the two chromosomes eight markers with highly
Figure 1. Q–Q plot comparing rl with a standard normal distribution and the
corresponding histograms for the trait LDL-C, HDL-C and TG.
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negative rl scores for HDL-C and highly positive rl scores for
TG from the analysis, the correlation declined only to 20.53,
which was still statistically significant (P ¼ 0.028). After
removal of the markers on chromosomes 8q and 15q, the cor-
relation still trended in the same direction but was no longer
significant (P ¼ .063). To assess whether the regressions of
HDL-C and TG on total European IA could be attributed
solely to ancestry at the peak location on chromosome 8q,
we performed a regression analysis of HDL-C (and TG)
including both 8q locus-specific European ancestry and total
European ancestry in the model. For both lipids, total Euro-
pean IA was no longer significant (and regression coefficients
were close to 0), once the locus-specific European ancestry
was included in the model. Hence, the overall ancestry
effect we observed for both lipids could be explained simply
by a locus on chromosome 8q, although the situation may
be more complex, with other loci contributing.
DISCUSSION
Numerous genes have been directly implicated in the variation
of lipid traits such as apolipoproteins (APOA1, APOA2,
APOA4, APOE), ATP-binding cassette sub-family A
member 1 (ABCA1), lecithin cholesterol acyltransferase
(LCAT) and lipoprotein lipase (LPL), among others (16,38–
43). All these genes have been extensively studied and well-
characterized biochemically. With the exception of APOE,
variants in the above-mentioned genes and a few others have
been found mostly in Mendelian disorders involving lipid
metabolism. Identifying more common and/or less penetrant
variants affecting lipid levels has been a more challenging
endeavor.
Among the three lipid traits we studied, LDL-C had the
least significant results. Although no points for LDL-C were
formally significant, we did note a modest increase in
markers correlated with excess African ancestry on chromo-
somes 3q and 4q. The region on chromosome 3q was pre-
viously identified in a linkage study with 470 subjects in 10
pedigrees with a maximum LOD score of 4.1 (44), but not
in other linkage and association studies. On chromosome 4q,
the marker D4S2367, which had the second lowest rl value,
is close to the SNP rs10518072. This SNP was associated
with LDL-C levels in the Framingham Heart genome-wide
association study (P ¼ 1.4  1024) (13) but was not reported
by Willer et al. (15) study.
In contrast, the results for HDL-C were more significant.
Most of the markers in the extreme left tail (negative corre-
lation with European ancestry) are on chromosomes 8q and
14q. The peak region on chromosome 8q (at 82 cM), our
most significant finding overall, also showed evidence of posi-
tive correlation of European ancestry with TG. Deviations in
the other tail of the Z-score distribution were more subtle
and less significant. Three consecutive markers on chromo-
some 9q showed up in this tail, with a peak between 104
and 111 cM.
Of interest, the region on chromosomes 9q22–q32 that we
identified harbors the ABC1 (ATP-binding cassette) gene at
9q31. ABC1 has long been associated with studies involving
HDL-C and is regarded as a candidate gene for HDL-C
deficiency and other related phenotypes (45–48). Mutations
in ABC1 can cause Tangier disease, a genetic disorder of
cholesterol characterized by very low levels of HDL-C
(46,47,49–52). Hence, ABC1 would be a candidate for an
HDL-C quantitative trait locus (QTL) in our analysis as well.
The three markers in our study, which were clearly signifi-
cant after permutation testing, are D8S1113 and D8S1136
from the region 8q11.23–q21.11 and GATA193A07 from
the region 14q24.1–q31. The region 8q11.23–q21.11 is the
location of the CYP7A1 gene at 8q12.1. This gene encodes a
member of the cytochrome P450 superfamily of enzymes
which catalyze many reactions involved in drug metabolism
and synthesis of cholesterol, steroids and other lipids. This
region also harbors the candidate gene CYP7B1 (at 8q12.3;
65.6 Mb from pter) between the markers D8S1113 and
D8S1136. Little other evidence in the literature implicates
this region of 8q in HDL-C or TG levels, suggesting our
results may be indicating a novel locus. In a study of lipid
levels among 113 Hispanic families, the GATA193A07
marker on chromosome 14 showed modest evidence of
linkage for TG (two point LOD score 2.12) and for the ratio
of TG to HDL-C (two point LOD score 2.46) (52). Weak evi-
dence of linkage to the locus was also obtained in a genome
scan of QTLs influencing HDL-C levels (19,53).
Figure 2. Overview of the Z-scores and its inverse relationship for HDL-C and
TG across chromosomes 8 and 14.
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Analysis of TG did not reveal any formally significant loci,
although there was an overall excess of observations in the
right tail of the Z-score distribution. This excess was due to
a preponderance of loci on chromosome 8. Three of these
loci overlapped with our most significant region for HDL-C
at 8q11–q21, whereas four other markers mapped to a non-
overlapping, more distal location between 8q23 and q24. We
do note, however, that rs7007075, the SNP most strongly
associated (P , 7.7  1026) with TG levels in the Framing-
ham Heart genome-wide association study, lies in this
region. The SNP rs17321515 (8q24.13) at 30 downstream of
the gene TRIB1 has been one of the most significant findings
(P¼4  10217) of genome-wide association studies (12).
This study also reported five independently associated SNPs
in this region, all of which lie within the two consecutive
markers D8S592 at 8q24.11 and D8S1179 at 8q24.13,
included in our study. The rl value corresponding to the
marker D8S1179 (2.59) and D8S592 (2.48) for TG are the
highest and the third highest that we found in our study (Sup-
plementary Material, Table S3).
As noted by us and others, the various lipid fractions are
modestly correlated within individuals. The largest correlation
is the negative association between HDL-C and TG. Prior
studies have suggested this correlation is, in part, genetically
determined (44,54–62). Thus, it is appropriate in any
genomic analysis to search for genes underlying the joint dis-
tribution of these traits.
In our admixture mapping analysis, we therefore searched
for locations potentially underlying multiple traits. Examin-
ation of the joint distribution of regression coefficients for
HDL-C and TG did indeed demonstrate a correlation
(20.55) that was statistically significant based on a permu-
tation analysis. The excess correlation over expected was
due partially but not exclusively to markers on chromosomes
8q and 15q, suggesting a possible multi-genic contribution
to this correlation.
Admixture mapping analysis is complementary to other
gene mapping approaches such as QTL linkage analysis and
genome-wide association studies. The power of the method
depends both on a measurable effect influencing the trait of
interest and on a sizeable difference in allele frequency
between ancestral populations, in this case Europeans and
Africans. Some of our more significant findings overlapped
with prior linkage and genome-wide association studies, and
these indicate chromosome regions for more detailed study
in follow-up. However, the degree of overlap among these
approaches depends on a number of factors, including the
underlying allele frequencies and degree of linkage disequili-
brium between trait-associated alleles and marker SNPs.
The power of admixture mapping is also dependent upon
the accuracy of the estimates of locus-specific ancestry.
Ancestry informativeness of the marker set that we have
used is on an average 50% and never falls , 40% (33).
Of note, the direction of our significant findings for HDL-C
and TG and lack of significant findings for LDL-C are consist-
ent with a genetic contribution to the known ethnic difference
for HDL-C and TG. Specifically, the regression coefficient we
obtained for European IA on (untransformed) HDL-C (28.18)
can fully explain the observed Black–White differences in
HDL-C. If we assume that African-Americans have 15%
European ancestry, on average (36), then the expected differ-
ence between Whites and African-Americans would be 85%
of 28.18 or 26.95. In our sample, the standard deviation of
HDL-C was 16.80, so the projected difference of 26.95
units corresponds 0.4 standard deviations, a figure compar-
able to the ethnic difference observed in two large studies
(24,25). Similarly, the regression coefficient of European IA
on (untransformed) TG levels was 64.47. The standard devi-
ation of TG in our sample was 76.36. Therefore, the predicted
ethnic difference from our analysis would be 85% of 64.47 ¼
54.80, which corresponds 0.7 standard deviations, again
comparable to the differences observed for US Blacks and
Whites (24,25).
To our knowledge, this is the largest quantitative admixture
mapping effort of blood lipid levels in terms of sample size
and marker locus involvement. Overall, our findings are
encouraging and provide regions for follow-up analyses of
genes influencing HDL-C and TG, and possibly LDL-C in
these and other African-American individuals.
MATERIALS AND METHODS
Subjects
The FBPP is a large multicenter genetic study of high blood
pressure and related traits in multiple racial/ethnic groups,
including European-Americans, African-Americans, Mexican
Americans and Asians and Asian Americans (63). It includes
four component networks: GenNet, GENOA, HyperGEN and
SAPPHIRE. GenNet, GENOA and HyperGEN who indepen-
dently collected samples from European-American and
African-American families.
All the individuals we included in this study were unrelated
self-identified African-Americans from the field centers of
GENOA and HyperGEN for whom fasting plasma lipid con-
centrations were available. To maximize the number of unre-
lated individuals in our sample, whenever possible we selected
unrelated founder individuals; otherwise we chose at random
one individual per family. Our final sample of 1044 individ-
uals consisted of 349 individuals sampled by the GENOA
network and 695 individuals sampled by the HyperGEN
network. Out of these 1044 individuals, 32 did not have
their LDL-C on record, so all our findings for LDL-C are
based on 1012 individuals, whereas those for HDL-C and
TG are based on 1044 individuals. There were 57 individuals
(52 for LDL-C) who were noted to be taking lipid-lowering
medication. The two networks included in this study measured
fasting plasma lipids using standard enzymatic methods in lab-
oratories participating in the CDC standardization program.
All individuals who participated in the FBPP gave informed
consent; the Institutional Review Board at each clinic site
approved all protocols, and a Certificate of Confidentiality
was obtained from the Federal Government for this study.
Genotyping
DNA was extracted from whole blood by standard methods by
each of the four FBPP networks and was sent to the US
National Heart, Lung and Blood Institute’s Mammalian geno-
typing service in Marshfield, Wisconsin, for genotyping.
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Screening set 8 (372 highly polymorphic microsattelite
markers with an average inter-marker map distance of
10 cM) was used.
Statistical analysis
We used the computer program Structure (64,65) to estimate
genome-wide, as well as site-specific IAs in all
African-American participants. The linkage model was used,
with genetic distance between markers specified according
to the Marshfield map. In each analysis, the Markov Chain
Monte Carlo algorithm was run for 100 000 steps of burn-in
followed by another 100 000 steps. We assumed a model
with two ancestral populations. We included 1378 unrelated
non-Hispanic White participants from the FBPP to represent
the European ancestral population as well as 127 unrelated
sub-Saharan African individuals from the Human Genome
Diversity Project to represent the African ancestral population
(66). The latter set of individuals had been genotyped at more
than 300 short tandem repeat at the time of our analysis, and
we included genotypes at 284 markers which were overlap-
ping with the FBPP genotypes.
The distributions of all three lipid traits for the 1044 (1012
for LDL-C) unrelated individuals were non-normal due to
positive skewness. The best normalization of the LDL-C
data was obtained using the Box–Cox power transformation
(67) with parameter (l) 0.69, whereas the value of l was
20.33 and 20.14, respectively, for HDL-C and TG.
We first calculated regression coefficients for each of the
transformed lipid traits on overall European IA, allowing for
covariates. Then, for each individual at each locus, a European
ancestry deviation xl was defined as the estimated ancestry at
locus l minus the background ancestry estimated from the
genome-wide markers for that individual, as previously
described (68). The variable xl was then used as the primary
independent variable in a linear regression model with the
quantitative trait value of LDL-C or HDL-C or TG as the
dependent variable. Log–log transformed BMI, age, sex and
network were included as covariates in this analysis, if signifi-
cant. The use of lipid-lowering medication was not found to be
significant for any of the traits, possibly due to the small
number of individuals (n ¼ 57) on medication. Hypertension
status was also included as a covariate, but was not significant
for any of the traits. We also checked for possible two factor
interactions and none was significant. All non-significant cov-
ariates and interactions were dropped from the model in sub-
sequent analyses. The standardized regression coefficient of
rl, defined as, was assumed to be distributed as asymptotically
normal and was used to assess statistical significance. To
account for multiple testing (284 markers), we performed a
permutation analysis in which we randomly reassigned the
vector of genetic ancestry estimates for the 284 marker
locations to individuals whose LDL-C, HDL-C, TG and cov-
ariate data remained intact. This procedure preserved the cor-
relation structure of the markers and the correlation structure
of the traits and covariates, but dissociated the relationship
between the markers and phenotypes. For each permuted
dataset, we performed the same regression analysis of the
traits on excess ancestry at each marker location, as was
done for the original data, and obtained the most extreme
values (positive and negative) of rl (the Z-score statistics).
Five thousand permutations were performed. To derive
P-values adjusted for multiple testing, we determined the per-
centage of times out of 5000 permutations that an observed
value of rl was exceeded in the permuted data analysis.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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